For the quarter ending 2025-09-30, ASPN had -$15,600K decrease in cash & cash equivalents over the period. $5,933K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | -6,334 | -310,305 |
| Depreciation | 5,392 | 11,589 |
| Amortization of debt issuance costs | 951 | 1,612 |
| Provision for bad debt | -4 | 32 |
| Stock-based compensation expense | 2,183 | 4,767 |
| Impairment of property, plant and equipment | -2 | 288,021 |
| Reduction in the carrying amount of operating lease right-of-use assets | -828 | -1,844 |
| Accounts receivable | -7,022 | -32,905 |
| Inventories | -9,078 | 4,564 |
| Prepaid expenses and other assets | 361 | -14,782 |
| Accounts payable | -1,151 | -14,579 |
| Accrued expenses | 21 | -20,931 |
| Deferred revenue | 200 | -1,575 |
| Operating lease liabilities | - | -1,896 |
| Operating lease and other liabilities | -4,684 | - |
| Net cash provided by operating activities | 15,035 | 1,702 |
| Capital expenditures | 9,102 | 25,883 |
| Net cash used in investing activities | -9,102 | -25,883 |
| Proceeds from employee stock option exercises | 1,185 | 231 |
| Repayment of lease and other finance obligations | 1,349 | 2,464 |
| Payments made for employee restricted stock tax withholdings | 69 | 602 |
| Repayment of revolving line of credit | 14,800 | 13,200 |
| Repayment of term loan | 6,500 | 13,000 |
| Fees and issuance costs from offering of common stock | 0 | 28 |
| Net cash provided by (used in) financing activities | -21,533 | -29,063 |
| Net decrease in cash, cash equivalents and restricted cash | -15,600 | -53,244 |
| Cash and cash equivalents at beginning of period | 221,276 | - |
| Cash and cash equivalents at end of period | 152,432 | - |
ASPEN AEROGELS INC (ASPN)
ASPEN AEROGELS INC (ASPN)